Should oral anticoagulation be discontinued after 3 months in the setting of a first high-risk pulmonary embolism secondary to a major transient/reversible risk factor?
Hans SlabbynckJohan ClukersDaniella GaldermansPublished in: The European respiratory journal (2020)